article thumbnail

STAT+: Teva agrees to pay $450 million to settle kickback and price-fixing allegations

STAT

Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies. At the same time, Teva steadily raised the price of its drug by thousands of dollars. At the same time, Teva steadily raised the price of its drug by thousands of dollars.

article thumbnail

Building New Data Connections Helps Brands Lower Adherence

Drug Channels

Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about the ConnectiveRx Enterprise Data Platform.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Building New Data Connections Helps Brands Lower Adherence Barriers

Drug Channels

Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about the ConnectiveRx Enterprise Data Platform.

article thumbnail

Three Digital Intake Strategies For Eliminating Patient Enrollment Forms

Drug Channels

He then explains three ways that specialty pharmaceutical companies can use digital intake strategies to speed patient enrollment. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Adam’s insights.

article thumbnail

Improving Out-of-Pocket Cost Transparency For Physicians

Drug Channels

Divya then explains how GoodRx partners with pharmaceutical companies to improve cost transparency and communication between patients and providers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn more about how GoodRx helps brand teams engage providers in specific specialties.

article thumbnail

Latest CMS Data Reveal the Truth About U.S. Drug Spending

Drug Channels

Tomorrow, we’ll be treated to a Senate show trial featuring pharmaceutical company executives. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. healthcare expenditures. Will drug pricing flat earthers (#DPFE) ever acknowledge the data?

article thumbnail

Gilead wins patent battle with US government over HIV PrEP drugs

Pharmaceutical Technology

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. In November 2019, the government sued Gilead over the company’s alleged patent infringement of the two PrEP drugs Descovy and Truvada.